-
Study aim
-
Evaluation of the effect of "Botox in addition to diltiazem ointment" in the treatment of chronic anal fissure
-
Design
-
A prospective randomized controlled clinical trial, phase 3, is conducted on 64 patients with chronic anal fissure. For randomization, first 64 balls from number 1 to 64 are considered and then randomly divided into two equal parts including group 1 (intervention) and group 2 (control) and then using a lottery container, the ball of each group was taken out and the intended sequence was recorded.
-
Settings and conduct
-
Eligible patients referred to Kosar Hospital in Semnan will be examined after being assigned to the intervention or control group and receiving the intervention. Patients are visited in future at intervals of 3, 6, and 12 weeks after the intervention, and each time fissure's degree, pain score, bleeding, gas or stool incontinence will be assessed.
-
Participants/Inclusion and exclusion criteria
-
64 patients with chronic fissure with a posterior or anterior linear ulcer and a skin tag, induration of the wound edges, visible internal sphincter muscle fibers in the wound base and symptoms of pain and bleeding following defecation for at least 8 weeks were included in the study. Patients with fistula, anal abscess, symptomatic hemorrhoids, acute fissure (less than eight weeks of symptoms), irritable bowel syndrome, and a history of anal surgery, pregnancy, or breastfeeding are excluded.
-
Intervention groups
-
In both groups, patients receive 20 units of Botox. We recommend that all patients follow a high-fiber diet. In the case group, 2% diltiazem ointment is prescribed after Botox injection. In future, fissure's degree, pain score, bleeding, gas or stool incontinence will be assessed.
-
Main outcome variables
-
Degree of anal fissure